Details for New Drug Application (NDA): 019668
✉ Email this page to a colleague
The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 019668
Tradename: | CARDURA |
Applicant: | Viatris |
Ingredient: | doxazosin mesylate |
Patents: | 0 |
Pharmacology for NDA: 019668
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for 019668
Suppliers and Packaging for NDA: 019668
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARDURA | doxazosin mesylate | TABLET;ORAL | 019668 | NDA | ROERIG | 0049-2410 | 0049-2410-10 | 100 TABLET in 1 BOTTLE (0049-2410-10) |
CARDURA | doxazosin mesylate | TABLET;ORAL | 019668 | NDA | ROERIG | 0049-2512 | 0049-2512-10 | 100 TABLET in 1 BOTTLE (0049-2512-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Nov 2, 1990 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Nov 2, 1990 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Nov 2, 1990 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019668
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-004 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-001 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription